For example, miR-26b-5p is reported as a potent inhibitor of the nuclear factor kappa-B (NF-κB) pathway by targeting TGF-beta activated kinase 1 (TAK1) and TGF-beta activated kinase 1 binding protein 3 (TAB3) in hepatocellular carcinoma [14]. Here, TAB3 is linked to hepatocellular carcinoma.